Pyridopyrimidinone Inhibitors Of Kinases


Ontology type: sgo:Patent     


Patent Info

DATE

2013-08-29T00:00

AUTHORS

WOODS KEITH W , MASTRACCHIO ANTHONY , LAI CHUNQIU , GANDHI VIRAJ B , PENNING THOMAS D

ABSTRACT

The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts, wherein R1, R2, R3, R4, and B are defined in the description. The present invention relates also to compositions containing said compounds which are useful for inhibiting kinases such as wee-1 and methods of treating diseases such as cancer. More... »

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/03", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0305", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "WOODS KEITH W", 
        "type": "Person"
      }, 
      {
        "name": "MASTRACCHIO ANTHONY", 
        "type": "Person"
      }, 
      {
        "name": "LAI CHUNQIU", 
        "type": "Person"
      }, 
      {
        "name": "GANDHI VIRAJ B", 
        "type": "Person"
      }, 
      {
        "name": "PENNING THOMAS D", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s11172-009-0273-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029383892", 
          "https://doi.org/10.1007/s11172-009-0273-2"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2013-08-29T00:00", 
    "description": "

The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts,

\n

\n \n \"embedded\n \n \n \n \n \n

\n

wherein R1, R2, R3, R4, and B are defined in the description. The present invention relates also to compositions containing said compounds which are useful for inhibiting kinases such as wee-1 and methods of treating diseases such as cancer.

", "id": "sg:patent.US-20130225589-A1", "name": "PYRIDOPYRIMIDINONE INHIBITORS OF KINASES", "recipient": [ { "id": "http://www.grid.ac/institutes/grid.431072.3", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/US-20130225589-A1" ], "sdDataset": "patents", "sdDatePublished": "2022-01-01T19:32", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/patent/patent_14.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.US-20130225589-A1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.US-20130225589-A1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.US-20130225589-A1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.US-20130225589-A1'


 

This table displays all metadata directly associated to this object as RDF triples.

45 TRIPLES      14 PREDICATES      16 URIs      8 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.US-20130225589-A1 schema:about anzsrc-for:03
2 anzsrc-for:0305
3 schema:author N15291576281943d89cf70a36e3f2712b
4 schema:citation sg:pub.10.1007/s11172-009-0273-2
5 schema:datePublished 2013-08-29T00:00
6 schema:description <p id="p-0001" num="0000">The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts,</p> <p id="p-0002" num="0000"> <chemistry id="CHEM-US-00001" num="00001"> <img id="EMI-C00001" he="27.26mm" wi="62.31mm" file="US20130225589A1-20130829-C00001.TIF" alt="embedded image" img-content="chem" img-format="tif" orientation="portrait" inline="no"/> <attachments> <attachment idref="CHEM-US-00001" attachment-type="cdx" file="US20130225589A1-20130829-C00001.CDX"/> <attachment idref="CHEM-US-00001" attachment-type="mol" file="US20130225589A1-20130829-C00001.MOL"/> </attachments> </chemistry> </p> <p id="p-0003" num="0000">wherein R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>, R<sup>4</sup>, and B are defined in the description. The present invention relates also to compositions containing said compounds which are useful for inhibiting kinases such as wee-1 and methods of treating diseases such as cancer.</p>
7 schema:name PYRIDOPYRIMIDINONE INHIBITORS OF KINASES
8 schema:recipient grid-institutes:grid.431072.3
9 schema:sameAs https://app.dimensions.ai/details/patent/US-20130225589-A1
10 schema:sdDatePublished 2022-01-01T19:32
11 schema:sdLicense https://scigraph.springernature.com/explorer/license/
12 schema:sdPublisher N286d84cca4354f10b212150fd4797e72
13 sgo:license sg:explorer/license/
14 sgo:sdDataset patents
15 rdf:type sgo:Patent
16 N14ef95fc0bb24a798cbcc0e5c8df27f3 schema:name GANDHI VIRAJ B
17 rdf:type schema:Person
18 N15291576281943d89cf70a36e3f2712b rdf:first Nd40557d118544e15aea37997b0b25b05
19 rdf:rest Na394aa8449b34c859c0ab841dbf0e7a4
20 N1f4b9afffb6f49bfbbe3ed6668a8008f rdf:first Nd97974e4c9d44b3b8c09d83051d9b7a2
21 rdf:rest rdf:nil
22 N286d84cca4354f10b212150fd4797e72 schema:name Springer Nature - SN SciGraph project
23 rdf:type schema:Organization
24 N7d820ad8b96b4057a494324dd638ad3e schema:name LAI CHUNQIU
25 rdf:type schema:Person
26 N9050b6ed6ff74a8981013dbaae4c91f4 schema:name MASTRACCHIO ANTHONY
27 rdf:type schema:Person
28 Na394aa8449b34c859c0ab841dbf0e7a4 rdf:first N9050b6ed6ff74a8981013dbaae4c91f4
29 rdf:rest Nca55ecd85f2944d4aea2d757ac322cfd
30 Nb2006efa25054dc88db4a6d50ffb74aa rdf:first N14ef95fc0bb24a798cbcc0e5c8df27f3
31 rdf:rest N1f4b9afffb6f49bfbbe3ed6668a8008f
32 Nca55ecd85f2944d4aea2d757ac322cfd rdf:first N7d820ad8b96b4057a494324dd638ad3e
33 rdf:rest Nb2006efa25054dc88db4a6d50ffb74aa
34 Nd40557d118544e15aea37997b0b25b05 schema:name WOODS KEITH W
35 rdf:type schema:Person
36 Nd97974e4c9d44b3b8c09d83051d9b7a2 schema:name PENNING THOMAS D
37 rdf:type schema:Person
38 anzsrc-for:03 schema:inDefinedTermSet anzsrc-for:
39 rdf:type schema:DefinedTerm
40 anzsrc-for:0305 schema:inDefinedTermSet anzsrc-for:
41 rdf:type schema:DefinedTerm
42 sg:pub.10.1007/s11172-009-0273-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029383892
43 https://doi.org/10.1007/s11172-009-0273-2
44 rdf:type schema:CreativeWork
45 grid-institutes:grid.431072.3 schema:Organization
 




Preview window. Press ESC to close (or click here)


...